208 related articles for article (PubMed ID: 29643985)
1. Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.
Bii VM; Collins CP; Hocum JD; Trobridge GD
Oncotarget; 2018 Mar; 9(21):15451-15463. PubMed ID: 29643985
[TBL] [Abstract][Full Text] [Related]
2. A novel approach to identify driver genes involved in androgen-independent prostate cancer.
Schinke EN; Bii V; Nalla A; Rae DT; Tedrick L; Meadows GG; Trobridge GD
Mol Cancer; 2014 May; 13():120. PubMed ID: 24885513
[TBL] [Abstract][Full Text] [Related]
3. Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors.
Bii VM; Trobridge GD
Cancers (Basel); 2016 Oct; 8(11):. PubMed ID: 27792127
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.
Nalla AK; Williams TF; Collins CP; Rae DT; Trobridge GD
Mol Carcinog; 2016 Nov; 55(11):1761-1771. PubMed ID: 26512949
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis Screens for Prostate Cancer Using Replication-Incompetent Lentiviral Vectors.
Trobridge GD
Methods Mol Biol; 2019; 1907():103-114. PubMed ID: 30542994
[TBL] [Abstract][Full Text] [Related]
6. A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker.
Bii VM; Rae DT; Trobridge GD
Oncotarget; 2015 Nov; 6(37):39507-20. PubMed ID: 26506596
[TBL] [Abstract][Full Text] [Related]
7. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
8. Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations.
Cesana D; Sgualdino J; Rudilosso L; Merella S; Naldini L; Montini E
J Clin Invest; 2012 May; 122(5):1667-76. PubMed ID: 22523064
[TBL] [Abstract][Full Text] [Related]
9. Insertional gene activation by lentiviral and gammaretroviral vectors.
Bokhoven M; Stephen SL; Knight S; Gevers EF; Robinson IC; Takeuchi Y; Collins MK
J Virol; 2009 Jan; 83(1):283-94. PubMed ID: 18945765
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
[TBL] [Abstract][Full Text] [Related]
11. Cancer gene discovery: exploiting insertional mutagenesis.
Ranzani M; Annunziato S; Adams DJ; Montini E
Mol Cancer Res; 2013 Oct; 11(10):1141-58. PubMed ID: 23928056
[TBL] [Abstract][Full Text] [Related]
12. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.
Modlich U; Navarro S; Zychlinski D; Maetzig T; Knoess S; Brugman MH; Schambach A; Charrier S; Galy A; Thrasher AJ; Bueren J; Baum C
Mol Ther; 2009 Nov; 17(11):1919-28. PubMed ID: 19672245
[TBL] [Abstract][Full Text] [Related]
13. Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter.
Yu D; Jia WW; Gleave ME; Nelson CC; Rennie PS
Prostate; 2004 Jun; 59(4):370-82. PubMed ID: 15065085
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis.
Woods NB; Muessig A; Schmidt M; Flygare J; Olsson K; Salmon P; Trono D; von Kalle C; Karlsson S
Blood; 2003 Feb; 101(4):1284-9. PubMed ID: 12393514
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials].
Doi K; Takeuchi Y
Uirusu; 2015; 65(1):27-36. PubMed ID: 26923955
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hematopoietic Stem Cell Engraftment Genes in Gene Therapy Studies.
Powers JM; Trobridge GD
J Stem Cell Res Ther; 2013 Sep; 2013(Suppl 3):S3:004-. PubMed ID: 24383045
[TBL] [Abstract][Full Text] [Related]
17. A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance.
Everson EM; Olzsko ME; Leap DJ; Hocum JD; Trobridge GD
Mol Ther Methods Clin Dev; 2016; 3():16048. PubMed ID: 27579335
[TBL] [Abstract][Full Text] [Related]
18. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.
Montini E; Cesana D; Schmidt M; Sanvito F; Bartholomae CC; Ranzani M; Benedicenti F; Sergi LS; Ambrosi A; Ponzoni M; Doglioni C; Di Serio C; von Kalle C; Naldini L
J Clin Invest; 2009 Apr; 119(4):964-75. PubMed ID: 19307726
[TBL] [Abstract][Full Text] [Related]
19. The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis.
Nowrouzi A; Cheung WT; Li T; Zhang X; Arens A; Paruzynski A; Waddington SN; Osejindu E; Reja S; von Kalle C; Wang Y; Al-Allaf F; Gregory L; Themis M; Holder M; Dighe N; Ruthe A; Buckley SM; Bigger B; Montini E; Thrasher AJ; Andrews R; Roberts TP; Newbold RF; Coutelle C; Schmidt M; Themis M
Mol Ther; 2013 Feb; 21(2):324-37. PubMed ID: 23299800
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer.
Ranzani M; Cesana D; Bartholomae CC; Sanvito F; Pala M; Benedicenti F; Gallina P; Sergi LS; Merella S; Bulfone A; Doglioni C; von Kalle C; Kim YJ; Schmidt M; Tonon G; Naldini L; Montini E
Nat Methods; 2013 Feb; 10(2):155-61. PubMed ID: 23314173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
